Replies to post #59 on BeyondSpring Inc (BYSI)

[crudeoil24]

BeyondSpring To Present Final Phase 3 DUBLIN-3 Data With Plinabulin/Docetaxel Combination Versus Docetaxel Alone In 2nd/3rd Line Non-Small Cell Lung Cancer Patients With EGFR Wild Type At European Society for Medical Oncology 2021 Congress Sept. 16-21